CYRIL RAMAPHOSA|
AS the country strives to recover from the effects of COVID-19 pandemic, we are seeing science and innovation playing a far more prominent role both in our efforts to overcome the disease and rebuild our economy.
Last week I attended the launch of a state-of-the-art vaccine manufacturing campus in Cape Town. The facility forms part of a multi-million rand investment by the multinational technology company NANTWorks, which is headed by South African born scientist Dr Patrick Soon-Shiong.
South Africa already has advanced pharmaceutical manufacturing capabilities in companies like Aspen Pharmacare, Afrigen Biologics and Vaccines and Biovac Institute, which is a public-private initiative.
These projects will greatly aid South Africa in our quest to become a hub of scientific innovation, research and development, especially in vaccine manufacturing for COVID-19, cancer, tuberculosis and other future pandemics.
Thousands of miles away, in Cape Canaveral in the United States, the aerospace company
You’ve reached your free article limit
Subscribe to enjoy unlimited access to trusted journalism. Cancel anytime.
Subscribe nowNeed help? molokom@insidepolitic.co.za
